Bibliographic Details
| Title: |
A highly potent and specific MET therapeutic protein antagonist with both ligand-dependent and ligand-independent activity. |
| Authors: |
Olwill SA; Corresponding Authors: Shane A. Olwill, Pieris AG, Lise-Meitner-Strasse 30, 85354 Freising, Germany. olwill@pieris-ag.com., Joffroy C, Gille H, Vigna E, Matschiner G, Allersdorfer A, Lunde BM, Jaworski J, Burrows JF, Chiriaco C, Christian HJ, Hülsmeyer M, Trentmann S, Jensen K, Hohlbaum AM, Audoly L |
| Source: |
Molecular cancer therapeutics [Mol Cancer Ther] 2013 Nov; Vol. 12 (11), pp. 2459-71. Date of Electronic Publication: 2013 Sep 03. |
| Publication Type: |
Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: |
Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
